Contributed by Hal S. Stern, PhD and Frank M. LaFerla, PhD
It is our pleasure to congratulate Charles Glabe, Distinguished Professor of Molecular Biology and Biochemistry, on being named a 2020 fellow of the National Academy of Inventors.
Among his achievements, Professor Glabe is being recognized for the creation of antibodies that bind to the four kinds of proteins forming the amyloid associated with Alzheimer’s disease. The process enables scientists to detect individual forms of the disease more precisely. The antibodies can be used as a screening tool and could help develop immunotherapies that slow or even prevent Alzheimer’s.
Professor Glabe also invented a technique for examining hundreds of antibodies in an individual’s blood and identifying the disease-causing agents they target. He and his team are currently using the technique to compare findings among a group of COVID-19 patients with those from a sample of individuals without the disease to learn more about the body’s defenses.
The National Academy of Inventors Fellows Program is the organization’s highest professional distinction awarded solely to academic inventors to recognize innovation that has made a tangible difference in quality of life, economic development and society’s wellbeing.
UCI now has 12 National Academy of Inventors fellows and a total of 908 issued U.S. patents. On behalf of Chancellor Gillman, please join us in congratulating Professor Glabe on this achievement.
Hal S. Stern, PhD
Interim Provost and Executive Vice Chancellor
Chancellor’s Professor, Department of Statistics
Frank M. LaFerla, PhD
Dean, School of Biological Sciences
Chancellor’s Professor, Neurobiology and Behavior